Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Sep 06 04:00PM ET
111.77
Dollar change
0.00
Percentage change
0.00
%
IndexS&P 500 P/E32.23 EPS (ttm)3.47 Insider Own0.61% Shs Outstand244.00M Perf Week-0.38%
Market Cap27.25B Forward P/E13.21 EPS next Y8.46 Insider Trans-11.79% Shs Float242.36M Perf Month12.10%
Income851.00M PEG2.92 EPS next Q1.62 Inst Own90.70% Short Float2.77% Perf Quarter13.13%
Sales226.99B P/S0.12 EPS this Y1.35% Inst Trans0.13% Short Ratio3.40 Perf Half Y-1.67%
Book/sh-13.17 P/B- EPS next Y10.86% ROA1.92% Short Interest6.71M Perf Year28.10%
Cash/sh21.05 P/C5.31 EPS next 5Y11.03% ROE- 52W Range85.82 - 116.05 Perf YTD10.88%
Dividend Est.2.04 (1.83%) P/FCF8.38 EPS past 5Y-5.30% ROI46.12% 52W High-3.69% Beta0.62
Dividend TTM2.01 (1.80%) Quick Ratio0.56 Sales past 5Y9.33% Gross Margin3.16% 52W Low30.24% ATR (14)2.16
Dividend Ex-DateOct 01, 2024 Current Ratio0.98 EPS Y/Y TTM247.35% Oper. Margin0.94% RSI (14)64.69 Volatility2.02% 1.92%
Employees48900 Debt/Eq- Sales Y/Y TTM10.72% Profit Margin0.37% Recom2.44 Target Price118.28
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q480.95% Payout58.20% Rel Volume1.34 Prev Close111.77
Sales Surprise2.09% EPS Surprise6.12% Sales Q/Q12.00% EarningsAug 14 BMO Avg Volume1.97M Price111.77
SMA202.96% SMA509.72% SMA2007.36% Trades Volume2,640,539 Change0.00%
Date Action Analyst Rating Change Price Target Change
Feb-26-24Initiated Leerink Partners Outperform $125
Feb-09-24Upgrade Argus Hold → Buy
Jan-03-24Initiated Barclays Overweight $117
Dec-14-23Initiated Wells Fargo Underweight $96
Jul-10-23Downgrade Evercore ISI Outperform → In-line $100
Mar-31-23Initiated Citigroup Neutral $77
Feb-03-23Upgrade Robert W. Baird Neutral → Outperform $87 → $94
Nov-04-22Upgrade BofA Securities Underperform → Neutral $64 → $80
Aug-22-22Resumed Morgan Stanley Overweight $70 → $76
May-26-22Downgrade Barclays Overweight → Equal Weight
Aug-28-24 05:34PM
03:16PM
11:00AM
Aug-26-24 02:31PM
Aug-23-24 09:27PM
11:00AM Loading…
Aug-22-24 11:00AM
10:00AM
Aug-21-24 04:23PM
07:30AM
Aug-16-24 01:01AM
Aug-15-24 05:45PM
03:05AM
Aug-14-24 07:22PM
04:20PM
04:06PM
03:15PM Loading…
03:15PM
01:46PM
12:29PM
12:29PM
12:29PM
12:02PM
11:42AM
11:23AM
11:00AM
10:59AM
09:53AM
09:30AM
08:02AM
08:01AM
07:40AM
06:47AM Loading…
06:47AM
06:30AM
Aug-13-24 09:40AM
09:01AM
07:32AM
Aug-12-24 10:52AM
08:43AM
Aug-09-24 09:15AM
09:08AM
Aug-08-24 04:23PM
Aug-07-24 10:00AM
Aug-06-24 06:00PM
Jul-31-24 06:00PM
Jul-26-24 09:40AM
Jul-24-24 06:00PM
Jul-23-24 06:15PM
11:27AM
06:45AM
Jul-22-24 06:00AM
Jul-17-24 06:00PM
Jul-15-24 06:15PM
Jul-12-24 12:08PM
Jul-11-24 07:00AM
Jul-09-24 06:15PM
Jul-04-24 12:15PM
Jun-28-24 08:10PM
Jun-27-24 03:15PM
Jun-26-24 06:15PM
Jun-24-24 06:47AM
Jun-18-24 07:59PM
Jun-11-24 01:03PM
Jun-10-24 06:56AM
Jun-09-24 09:00AM
Jun-06-24 02:58PM
02:25PM
Jun-02-24 04:00PM
May-29-24 09:40AM
May-28-24 09:55AM
May-22-24 05:17PM
May-19-24 08:09AM
May-17-24 09:00AM
07:44AM
May-15-24 07:36AM
May-13-24 09:40AM
May-08-24 08:06PM
May-07-24 04:15PM
06:40AM
May-06-24 02:21PM
02:00PM
09:00AM
May-03-24 01:12PM
11:41AM
09:31AM
03:10AM
01:11AM
May-02-24 03:25PM
12:56PM
12:22PM
12:00PM
10:53AM
10:03AM
08:40AM
08:02AM
07:14AM
06:53AM
06:45AM
May-01-24 03:12PM
Apr-29-24 12:07PM
09:16AM
07:51AM
Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. It also provides medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. The firm operates through the Pharmaceutical and Medical segments. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products. The Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical, and laboratory products. The company was founded by Robert D. Walter in 1979 and is headquartered in Dublin, OH.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mayer Jessica LChief Legal/Compliance OfficerAug 21 '24Sale109.3916,5731,812,92075,971Aug 22 08:43 AM
Mayer Jessica LOfficerAug 21 '24Proposed Sale109.3916,5731,812,898Aug 21 04:25 PM
Mayer Jessica LChief Legal/Compliance OfficerAug 15 '24Option Exercise72.768,673631,017112,425Aug 19 08:30 PM
Mayer Jessica LChief Legal/Compliance OfficerAug 15 '24Sale106.4817,8961,905,56694,529Aug 19 08:30 PM
Alt Aaron EChief Financial OfficerAug 19 '24Sale108.912,323252,99836,867Aug 19 08:28 PM
Greene Michelle D.Chief Information OfficerAug 19 '24Sale108.854,000435,40019,242Aug 19 08:26 PM
Hollar Jason M.Chief Executive OfficerAug 19 '24Sale109.0246,4555,064,524197,636Aug 19 08:24 PM
Hollar Jason M.Chief Executive OfficerAug 16 '24Sale108.8726,7162,908,571244,091Aug 19 08:24 PM
Snow Ola MChief Human Resources OfficerAug 19 '24Option Exercise77.3817,6671,367,14762,163Aug 19 08:23 PM
Snow Ola MChief Human Resources OfficerAug 19 '24Sale109.0034,6473,776,52327,516Aug 19 08:23 PM
Snow Ola MChief Human Resources OfficerAug 16 '24Sale108.003,294355,75245,439Aug 19 08:23 PM
Mason Stephen MCEO, GMPD SegmentAug 19 '24Option Exercise83.6214,9611,251,07587,669Aug 19 08:21 PM
Mason Stephen MCEO, GMPD SegmentAug 19 '24Sale109.2146,9985,132,84840,671Aug 19 08:21 PM
Mason Stephen MOfficerAug 19 '24Proposed Sale109.2246,9985,132,896Aug 19 05:41 PM
Alt Aaron EOfficerAug 19 '24Proposed Sale108.912,323252,992Aug 19 05:05 PM
Greene Michelle D.OfficerAug 19 '24Proposed Sale108.854,000435,389Aug 19 05:05 PM
Hollar Jason M.OfficerAug 19 '24Proposed Sale109.0246,4555,064,517Aug 19 05:03 PM
Snow Ola MOfficerAug 19 '24Proposed Sale108.9934,6473,776,225Aug 19 04:55 PM
Snow Ola MOfficerAug 16 '24Proposed Sale107.993,294355,733Aug 16 04:15 PM
Hollar Jason M.OfficerAug 16 '24Proposed Sale108.8726,7162,908,665Aug 16 04:08 PM
Mayer Jessica LOfficerAug 15 '24Proposed Sale106.4817,8961,905,598Aug 15 02:46 PM
WEITZMAN DEBORAHCEO, Pharmaceutical SegmentNov 27 '23Option Exercise74.1027,6422,048,35671,844Nov 29 09:14 AM
WEITZMAN DEBORAHCEO, Pharmaceutical SegmentNov 27 '23Sale106.3136,6423,895,41135,202Nov 29 09:14 AM